The Wall Street Journal is reporting that Johnson & Johnson (NYSE:JNJ) agreed to pay at least $2.5 billion to settle thousands of U.S. product liability lawsuits filed over its recalled DePuy ASR metal-on-metal hip implant.
Metal-on-Metal
U.K. poised to ban metal-on-metal hips
Regulators in the U.K. are reportedly poised to ban the use of metal-on-metal hip implants after finding unacceptably high rates of failure in a review of 17,000 cases.
The proposed ban, which would affect hospitals in the U.K.’s National Health Service, follows a review by the country’s National Institute for Health & Care Excellence that found failure rates as high as 43% for some of the implants, The Telegraph reported.
Johnson & Johnson settles another DePuy ASR lawsuit
Johnson & Johnson (NYSE:JNJ) settled another of the thousands of lawsuits it’s facing over its recalled DePuy ASR metal-on-metal hip implant, according to court records.
Johnson & Johnson settles DePuy ASR bellwether ahead of trial
DePuy hip implant class action lawsuits spread north of the border
Judge delays 1st bellwether DePuy ASR trial
A federal judge delayed the 1st bellwether trial in the multi-district litigation over the DePuy ASR metal-on-metal hip implant, originally slated to begin this week.
Prosecutors say DePuy hid risks in ASR hip recall
Prosecutors involved in the high-profile bellwether lawsuit of Johnson & Johnson‘s (NYSE:JNJ) DePuy orthopedics division said there is growing evidence that company hid key information about the risks of its ASR metal-on-metal hip implant.
Biomet’s preemption bid fails, company proceeds to trial over metal hips
Biomet will go to bat over its M2A-magnum metal-on-metal hip implants after failing to convince an Indiana federal judge that a personal injury lawsuit was preempted by FDA rules.
Johnson & Johnson can exclude recall evidence in DePuy ASR bellwether lawsuit
UPDATED August 12, 2013, with information on a 3rd DePuy ASR trial.
Evidence of the recall of the DePuy ASR metal-on-metal hip implant can be excluded from a bellwether trial over the device, a federal judge ruled last month.
Plaintiffs in DePuy ASR lawsuits can add Pinnacle claims
Plaintiffs in 7 lawsuits filed over Johnson & Johnson‘s (NYSE:JNJ) recalled DePuy ASR hip implant can also file claims over the DePuy Pinnacle acetabular cup device, a state judge in California ruled last week.